Protection against irradiation-induced damage to salivary glands by adrenergic agonist administration.
OBJECTIVE
Irradiation [IR]-induced damage to major salivary glands is an entity first described at the beginning of our century, yet its underlying mechanism is still enigmatic. Exposure of the salivary glands to IR is often inevitable when delivering radiotherapy for malignancies of the head and neck region. Frequently, this results in rapidly developing, life-long severe xerostomia for which no adequate prevention or treatment is available. The purpose of this study was to examine the role of secretion granules in serous cells of the parotid (P) and submandibular (SM) glands as mediators in the IR-induced salivary damage. Functional parameters (flow rate and gland weight), and total body weight were examined at both early term (4 days) and extended term (2 months) post-IR in male Wistar rats exposed to 15 Gy of head and neck irradiation following stimulation for granule secretion (degranulation).


METHODS
At 4 days, it was demonstrated that IR reduced P flow rate, P gland weight, total body weight, and submandibular/sublingual gland weight by 89, 33, 30, and 32% (p < 0.01), respectively, while SM flow rate was not altered significantly. At 2 months, these parameters were reduced by 59, 37, 31, and 37%, respectively, and the SM flow rate was reduced by 39% (p < 0.01).


RESULTS
Pilocarpine, a muscarinsic agonist which, albeit its efficacy as a salivary watery secretion stimulator, causes only limited degranulation, did not protect significantly any of the reduced parameters at either term. In contrast, cyclocytidine, an adrenergic agonist that is a very potent salivary degranulating agent, protected the P against the weight loss at 4 days and 2 months, and against the flow rate reduction at 2 months. The P weight and flow rate were protected to the extent that their values were not significantly different than those of the nonirradiated controls. Cyclocytidine also partially protected against the body weight reduction at 2 months. Our results emphasize the importance of secretion granules as mediatory agents in IR-induced P damage, and more so at the extended term. The demonstrated protective role of adrenergic agonists against IR damage to the P may be of importance in the clinical setting.
Nagler
R M
RM
Department of Maxillofacial Surgery, Rambam Medical Center and Faculty of Medicine, Technion, Israel Institute of Technology, Haifa.
Laufer
D
D
D000322:Adrenergic Agonists / Q000494:pharmacology*; D003504:Ancitabine / Q000494:pharmacology; D000818:Animals; D015550:Cell Degranulation / Q000187:drug effects / Q000528:radiation effects; D003594:Cytoplasmic Granules / Q000187:drug effects / Q000528:radiation effects; D008297:Male; D010306:Parotid Gland / Q000187:drug effects* / Q000502:physiology / Q000528:radiation effects*; D010862:Pilocarpine / Q000494:pharmacology; D011833:Radiation Injuries, Experimental / Q000517:prevention & control*; D011835:Radiation Protection / Q000379:methods*; D051381:Rats; D017208:Rats, Wistar; D013363:Submandibular Gland / Q000187:drug effects* / Q000502:physiology / Q000528:radiation effects*
D000322:Adrenergic Agonists; D010862:Pilocarpine; D003504:Ancitabine